Expansion of Mail-Delivered Harm Reduction Services in the U.S.
扩大美国邮件递送减害服务
基本信息
- 批准号:10590378
- 负责人:
- 金额:$ 239.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcuteAddressAreaBlack raceBloodCOVID-19ClientCohort StudiesDevelopmentDiseaseDisease OutbreaksDistrict of ColumbiaDrug usageEnvironmentFaceFentanylFrightFutureHIV/HCVHarm ReductionHealthHealth ServicesHispanicHomeHourInjecting drug userInjectionsInterventionInterviewInvestigationLaw EnforcementLawsLegalLongitudinal cohort studyModalityNaloxoneNeedle-Exchange ProgramsOnline SystemsOverdose reversalParticipantPerceptionPersonsPharmacy facilityPoliciesPopulationPublic HealthReportingRiskRisk BehaviorsRouteRuralSample SizeSecureServicesSourceSurveysSyringesTaxonomyTechnologyTimeTransportationUnderserved PopulationWomanYouthacceptability and feasibilitybasedesignexperimental studyfollow-upgaps in accesshealth care deliveryhigh riskhousing instabilityimprovedinnovationinsightmeetingsopioid overdoseopioid useoverdose deathpeerpreferencepreventprogramsrecruitscale upsecondary analysisservice deliveryservice engagementsocial mediasocial stigmatest stripuptake
项目摘要
PROJECT SUMMARY
COVID-19 has led to record high overdose deaths in the US and high risk for future injection-related HIV and
hepatitis c (HCV) outbreaks. Innovative approaches are urgently needed to expand access to syringes and
naloxone, a drug used for opioid overdose reversal, for the prevention of HIV/HCV outbreaks and opioid
overdose fatalities. Expansion and scale-up of mail-based harm reduction services may address harm
reduction access gaps by providing a more convenient and confidential way to obtain services. To inform
scale-up these services, we aim to 1) describe policy barriers to national expansion of mail-based syringe
services and fentanyl strip distribution, 2) conduct a national, longitudinal cohort study to examine predictors of
uptake and long-term engagement in mail-based harm reduction services, and 3) assess the add-on harm
reduction and health services preferences of mail delivery clients. For Aim 1, we will conduct a systematic legal
review of relevant laws in each of the 50 states and the District of Columbia to determine whether and how
state law may impact the legality of distributing syringes and fentanyl test strips by mail. We will develop a
taxonomy of policies that may prevent legal expansion of mail-delivered syringes. To understand the
perception of legal risks associated with mailing syringes among potential adopters, we will survey and
interview 20 stakeholders (i.e., health departments and SSPs) from states representing different legal
environments for mail-delivery. For Aim 2, we will build on a social media-recruited survey examining uptake
and acceptability of mail-delivered harm reduction by expanding the follow up period of that survey from 6
months to 12 and 18 months and expanding the sample size of this survey. This will allow us to assess
predictors of uptake and mail-delivered harm reduction engagement over the long-term in order to fully
understand who uses mail-delivered services and how these services are being used over time. For Aim 3 we
will design and implement discrete choice experiment (DCE) surveys to determine mail-based service client
preferences for receiving add-on harm reduction and health services. These results will be disseminated to
policy stakeholders, potential adopters, and NEXT affiliates to inform expansion and scale-up of mail-based
harm reduction services, improve engagement with current NEXT users, and expand the type of services
offered through these programs.
项目摘要
COVID-19已导致美国创纪录的过量死亡人数,以及未来与注射相关的艾滋病毒的高风险,
丙型肝炎(HCV)爆发。迫切需要采取创新办法,扩大获得注射器的机会,
纳洛酮,一种用于阿片类药物过量逆转的药物,用于预防HIV/HCV爆发和阿片类药物
吸毒过量致死扩展和扩大基于邮件的减少危害服务可以解决危害
通过提供更方便和保密的方式获得服务,缩小获得服务的差距。通知
为了扩大这些服务,我们的目标是1)描述国家扩大邮寄注射器的政策障碍
服务和芬太尼条分布,2)进行一项全国性的纵向队列研究,以检查
接受和长期参与基于邮件的减少伤害服务,以及3)评估附加伤害
减少和健康服务的邮件交付客户的偏好。为了实现目标1,我们将进行系统的法律的
审查50个州和哥伦比亚特区的相关法律,以确定是否以及如何
州法律可能会影响通过邮件分发注射器和芬太尼测试条的合法性。我们将开发一个
可能阻止邮寄注射器的法律的扩展的政策分类。了解
对潜在采用者中与邮寄注射器相关的法律的风险的看法,我们将调查,
与20个利益攸关方进行访谈(即,代表不同法律的州的卫生部门和SSP
邮件递送的环境。对于目标2,我们将在社交媒体招募调查的基础上,
通过将该调查的随访期从6个月延长到6个月,
将调查时间延长至12个月和18个月,并扩大本次调查的样本量。这将使我们能够评估
长期采用和邮寄减少危害的预测因素,以便充分
了解谁使用邮件传递服务,以及这些服务在一段时间内如何使用。对于目标3,
将设计和实施离散选择实验(DCE)调查,以确定基于邮件的服务客户
优先接受附加的减少危害和保健服务。这些结果将分发给
政策利益相关者,潜在的采用者和NEXT附属机构,以告知扩展和扩大基于邮件的
减少伤害服务,改善与当前NEXT用户的接触,并扩大服务类型
通过这些方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Czarina Navos Behrends其他文献
Czarina Navos Behrends的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 239.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 239.34万 - 项目类别:
Standard Grant